Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Alcoholic Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Non-Alcoholic Steatohepatitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Non-Alcoholic Steatohepatitis 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Norgine BV 32
Clinical Trial Overview of Norgine BV 32
Raptor Pharmaceuticals Corp. 33
Clinical Trial Overview of Raptor Pharmaceuticals Corp. 33
Immuron Limited 34
Clinical Trial Overview of Immuron Limited 34
Gilead Sciences, Inc. 35
Clinical Trial Overview of Gilead Sciences, Inc. 35
Galmed International Ltd. 36
Clinical Trial Overview of Galmed International Ltd. 36
Galectin Therapeutics, Inc. 37
Clinical Trial Overview of Galectin Therapeutics, Inc. 37
CATALYSIS, S.L. 38
Clinical Trial Overview of CATALYSIS, S.L. 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Rottapharm|Madaus 40
Clinical Trial Overview of Rottapharm|Madaus 40
CROLLL GmbH 41
Clinical Trial Overview of CROLLL GmbH 41
NasVax Ltd. 42
Clinical Trial Overview of NasVax Ltd. 42
Intercept Pharmaceuticals, Inc. 43
Clinical Trial Overview of Intercept Pharmaceuticals, Inc. 43
Trophos SA 44
Clinical Trial Overview of Trophos SA 44
Phenex Pharmaceuticals AG 45
Clinical Trial Overview of Phenex Pharmaceuticals AG 45
Takeda Global Research and Development Center, Inc 46
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 46
Genfit SA 47
Clinical Trial Overview of Genfit SA 47
Zydus Cadila Healthcare Limited 48
Clinical Trial Overview of Zydus Cadila Healthcare Limited 48
Sanofi 49
Clinical Trial Overview of Sanofi 49
Astellas Pharma Inc. 50
Clinical Trial Overview of Astellas Pharma Inc. 50
Mochida Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Mochida Pharmaceutical Co., Ltd. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Yokohama City University 52
Clinical Trial Overview of Yokohama City University 52
Tehran University of Medical Sciences 53
Clinical Trial Overview of Tehran University of Medical Sciences 53
University of California, San Diego 54
Clinical Trial Overview of University of California, San Diego 54
Hadassah Medical Organization 55
Clinical Trial Overview of Hadassah Medical Organization 55
University of Michigan 56
Clinical Trial Overview of University of Michigan 56
The University of Texas Health Science Center at San Antonio 57
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 57
Hiroshima University Hospital 58
Clinical Trial Overview of Hiroshima University Hospital 58
Mayo Clinic 59
Clinical Trial Overview of Mayo Clinic 59
University of Zurich 60
Clinical Trial Overview of University of Zurich 60
Medical College of Wisconsin 61
Clinical Trial Overview of Medical College of Wisconsin 61
Northwestern University 62
Clinical Trial Overview of Northwestern University 62
University of Colorado 63
Clinical Trial Overview of University of Colorado 63
Imperial College London 64
Clinical Trial Overview of Imperial College London 64
Medical University of Vienna 65
Clinical Trial Overview of Medical University of Vienna 65
Case Western Reserve University 66
Clinical Trial Overview of Case Western Reserve University 66
Chinese University of Hong Kong 67
Clinical Trial Overview of Chinese University of Hong Kong 67
Centre Hospitalier Universitaire de Nice 68
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 68
Charles University 69
Clinical Trial Overview of Charles University 69
Lawson Health Research Institute 70
Clinical Trial Overview of Lawson Health Research Institute 70
RWTH Aachen University 71
Clinical Trial Overview of RWTH Aachen University 71
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2013* 46
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2013* 47
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2013* 52
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2013* 53
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 54
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 55
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 56
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2013* 57
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2013* 58
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 59
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 60
Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2013* 61
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013 published by GlobalData in January 31, 2013. This report consists of Pages: 98 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
